Viking Therapeutics, Inc. (VKTX)
NASDAQ • Healthcare
Last close at October 23, 2026 at 20:00 UTC
Metrics Over Time
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 28
in 3 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Viking Therapeutics topped EPS consensus on preliminary second fiscal quarter of 2026 results reported July 29, with EPS of -$1.10 against a -$1.23 estimate, +10.6%. Based on preliminary results, operating income was negative about $132.6 million, while net income was negative about $128.0 million, down 95.3% from negative about $65.6 million a year ago; EPS also was down 89.7% from -$0.58 a year ago. Operating cash flow was negative about $125.2 million, and consensus for the next period calls for EPS of -$1.07.
Next report — what to expect
Viking Therapeutics, Inc. (VKTX) reports next on October 28, 2026. Wall Street is looking for consensus EPS of -$1.068. Traders may focus on any update that could shift expectations versus that baseline, especially given VKTX has beaten EPS in 2 of 8 most recent quarters.
About Viking Therapeutics, Inc.
Viking Therapeutics, Inc. is a Nasdaq-listed healthcare company in biotechnology focused on clinical-stage drug development for metabolic and endocrine disorders. Trading on NASDAQ as VKTX, it advances a pipeline of investigational therapies rather than marketed products, with programs aimed at liver disease, diabetes, post-surgical recovery, and X-linked adrenoleukodystrophy.
Today's Snapshot
VKTX closed 5.5% below yesterday's close, in line with a weaker sector. At the close, VKTX was within 0.2% of its 52-week low of 24.36. Viking Therapeutics will release its financial report after the market closes on October 28.
Trading Volume
Below 10d avg (4.8M)
4.6M
vs S&P 500 Today
Strong Underperformance
-5.02%
Updated: October 23, 2026 at 20:21 UTC
VKTX Headlines
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$26.34 - $32.67Sell
- RSI (14)36.03Neutral
- Stochastic %K (14, 3, 3)13.72Buy
- MACD Level (12, 26)-1.93Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.